Telithromycin-induced acute interstitial nephritis: a first case report.

Tintillier, Michel;Kirch, Lotti;Almpanis, Carole;Cosyns, Jean-Pierre;Cuvelier, Charles;et.al.
(2004) American Journal of Kidney Diseases — Vol. 44, n° 2, p. e25-27 (2004)

Files

No attached file found for this publication.

Details

Authors
  • Tintillier, Michel
    Author
  • Kirch, Lotti
    Author
  • Almpanis, Carole
    Author
  • Cosyns, Jean-PierreUCLouvain
    Author
  • Cuvelier, Charles
    Author
Show more
Abstract
Telithromycin, a ketolide antibiotic used for the treatment of community-acquired respiratory infections, is widely prescribed in primary care practice. Treatment-related adverse events are mainly of gastrointestinal origin and generally mild in intensity. The authors report the first case of telithromycin-induced severe acute interstitial nephritis. Practitioners should be aware of the possibility that telithromycin therapy could result in this form of drug-induced acute renal failure.
Affiliations

Citations

Tintillier, M., Kirch, L., Almpanis, C., Cosyns, J.-P., Pochet, J.-M., & Cuvelier, C. (2004). Telithromycin-induced acute interstitial nephritis: a first case report. American Journal of Kidney Diseases, 44(2), e25-27. https://doi.org/10.1053/j.ajkd.2004.04.045 (Original work published 2004)